|
Nature of Operations and Basis of Presentation (Details) (USD $)
|
0 Months Ended | |
|---|---|---|
|
Jun. 03, 2011
|
Jan. 31, 2015
subsidiary
|
|
| Nature of operations and basis of presentation | ||
| Number of subsidiaries | 0oncs_NumberOfSubsidiaries | |
| OncoSec Medical Therapeutics | ||
| Nature of operations and basis of presentation | ||
| Total purchase price |
$ 1,000us-gaap_BusinessCombinationConsiderationTransferred1 / us-gaap_BusinessAcquisitionAxis = oncs_OncoSecMedicalTherapeuticsIncorporatedMember |
| X | ||||||||||
|
- Definition
Represents the number of subsidiaries of the Company. No definition available.
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|